Neostigmine methylsulfate
- Product NDC
- 70700-171
- Requested package NDC
- 70700-171-23
- 11-digit product format
- 707000171
- Labeler code
- 70700
- Product ID
- 70700-171_8649cf31-5ecf-2048-5bf0-1b6e84f190f4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Neostigmine methylsulfate
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Xiromed LLC
- Application
- ANDA212968
- Marketing category
- ANDA
- Marketing start
- 2020-09-09
- Substance
- NEOSTIGMINE METHYLSULFATE
- Active strength
- .5 mg/mL
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 70700-171 | 70700-171-23 | U | Excluded because listing certification expired | excluded / ndc_excluded.zip | 0efc9e666f02… | f202fb6c5f17… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A212968-001 | NEOSTIGMINE METHYLSULFATE | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | |
| A212968-002 | NEOSTIGMINE METHYLSULFATE | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A212968-001 | AP |
| A212968-002 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A212968-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A212968-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | A212968-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A212968-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A212968-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A212968-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A212968-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A212968-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212968-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212968-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212968-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212968-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212968-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212968-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212968-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212968-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212968-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212968-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212968-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212968-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212968-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212968-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A212968-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A212968-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A212968-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A212968-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A212968-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A212968-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A212968-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A212968-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A212968-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A212968-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A212968-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A212968-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A212968-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A212968-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A212968-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A212968-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A212968-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A212968-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2019-10-16 | 5d02ea3f76ae… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A212968-001 | AP | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A212968-002 | AP | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | A212968-001 | AP | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A212968-002 | AP | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A212968-001 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212968-002 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A212968-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A212968-002 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A212968-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212968-002 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212968-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212968-002 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A212968-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A212968-002 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212968-001 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212968-002 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212968-001 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212968-002 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212968-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A212968-002 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212968-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A212968-002 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A212968-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A212968-002 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A212968-001 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A212968-002 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A212968-001 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A212968-002 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A212968-001 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A212968-002 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A212968-001 | AP | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A212968-002 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A212968-001 | AP | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A212968-002 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A212968-001 | AP | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A212968-002 | AP | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A212968-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A212968-002 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A212968-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A212968-002 | AP | 1 | 5d02ea3f76ae… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Neostigmine methylsulfate
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| NEOSTIGMINE METHYLSULFATE | .5 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 98IMH7M386 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 801225d9-eb71-dbef-e860-4caf7a22f27f | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f58f10d3-5fa9-4c2e-9a6e-77029e9ed80b | Product name | 1 | 20231002 |
| 6c2b16d0-96e9-444e-98c5-9883cd6eb72d | Product name | 2 | 20230316 |
| 6bd95106-a412-1dad-b9cc-4cb74bfb27ce | Product name | 2 | 20230315 |
| ad279e69-d021-f6bd-1150-2b55f23832d5 | Product name | 9 | 20211014 |
| 48747306-602a-42cc-957b-5b0c69158eee | Product name | 1 | 20180604 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| 290f523a-f9db-9774-b5a9-e1f908ac1782 | Product name | 1 | 20150828 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| c6b65c52-69c7-df49-550a-a50c137f6218 | Product name | 1 | 20140508 |
| db5ebcdb-b6ae-21cd-4dc5-76cd84b5578b | Product name | 1 | 20140508 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70700-171-22 | ML - Milliliter | 70700-171 | 4da0af3e-a705-4573-b7a2-93a192c4c6bf | 1 | 2020-09-14 |
| 70700-171-23 | ML - Milliliter | 70700-171 | c2f8aae0-5db7-4b6c-ab85-15f52f483c00 | 1 | 2020-09-14 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Neostigmine methylsulfate | NEOSTIGMINE METHYLSULFATE | Gland Pharma Limited | 4eab6184-1771-4c15-a127-4eb3e47affc2 | 2026-09-21 | Warnings, Adverse reactions | 212968 ANDA212968 |
| Neostigmine methylsulfate | NEOSTIGMINE METHYLSULFATE | ProPharma Distribution | 3857462f-2d3c-bada-e063-6294a90a7438 | 2025-07-18 | Warnings, Adverse reactions | 212968 ANDA212968 |
| Neostigmine methylsulfate | NEOSTIGMINE METHYLSULFATE | Xiromed LLC | 801225d9-eb71-dbef-e860-4caf7a22f27f | 2021-10-13 | Warnings, Adverse reactions | 212968 ANDA212968 70700-171-23 70700-171 70700017123 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 311935 | neostigmine methylsulfate 0.5 MG/ML Injectable Solution | PSN | 801225d9-eb71-dbef-e860-4caf7a22f27f | 6 |
| 311936 | neostigmine methylsulfate 1 MG/ML Injectable Solution | PSN | 801225d9-eb71-dbef-e860-4caf7a22f27f | 6 |
| 311935 | neostigmine methylsulfate 0.5 MG/ML Injectable Solution | SCD | 801225d9-eb71-dbef-e860-4caf7a22f27f | 6 |
| 311936 | neostigmine methylsulfate 1 MG/ML Injectable Solution | SCD | 801225d9-eb71-dbef-e860-4caf7a22f27f | 6 |
| 311935 | neostigmine methylsulfate 0.5 MG/ML Injectable Solution | SY | 801225d9-eb71-dbef-e860-4caf7a22f27f | 6 |
| 311936 | neostigmine methylsulfate 1 MG/ML Injectable Solution | SY | 801225d9-eb71-dbef-e860-4caf7a22f27f | 6 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 70700-171-23 | 70700017123 | 10 VIAL, MULTI-DOSE in 1 CARTON (70700-171-23) / 10 mL in 1 VIAL, MULTI-DOSE | 2020-09-09 | 0000-00-00 | No | No | Current |